Sweat sensor test for cystic fibrosis
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This trial tests a new skin sensor that measures sweat to help diagnose cystic fibrosis. It compares results from people with CF and healthy volunteers to see if the device works accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years old or older
- Either have a confirmed diagnosis of cystic fibrosis or be a healthy volunteer
- Able to understand and speak English
- No other medical condition that could affect sweat chloride test results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that measures how your sweat glands react to a common asthma medication. It aims to better classify people with cystic fibrosis or related diseases, and also includes healthy volunteers and carriers.
This trial tests a new, simple device that measures sweat chloride (salt) levels at the doctor's office or even at home. The goal is to see how well this device works for monitoring how CF treatments are helping your body.
This study is a registry that collects health information (and some lab samples) from Chinese children who may have cystic fibrosis (CF). It helps researchers better understand CF in children and how it is diagnosed.
This study looks for simple signals (markers) that may show whether cystic fibrosis treatments are working. It includes people who take CF “modulator” medicines like ivacaftor, people who don’t, and people whose cystic fibrosis was ruled out after testing.
This study looks at new “imaging biomarkers” (MRI measurements) in children with cystic fibrosis (CF). It mainly aims to see how MRI findings might relate to starting the recommended CF triple-combination therapy.
This study tests new treatments for cystic fibrosis in people who cannot take or choose not to take current CFTR modulators. It aims to find better options for managing CF.
Hear when a new Cystic Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.